Tania F Gendron - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Tania F Gendron

Showing results (121-130 of 123) with videos related to

Pageof 13

Sort By:

You have reached the last page of results.This site can display upto 123 results.

Science Translational Medicine|October 22, 2020

Toward allele-specific targeting therapy and pharmacodynamic marker for spinocerebellar ataxia type 3Mercedes Prudencio, Hector Garcia-Moreno, Karen R Jansen-West, et al.

Science Translational Medicine|March 31, 2017

Poly(GP) proteins are a useful pharmacodynamic marker for <i>C9ORF72</i>-associated amyotrophic lateral sclerosisTania F Gendron, Jeannie Chew, Jeannette N Stankowski, et al.

Nature Medicine|September 22, 2022

Temporal order of clinical and biomarker changes in familial frontotemporal dementiaAdam M Staffaroni, Melanie Quintana, Barbara Wendelberger, et al.

Pageof 13

Search research articles

Showing results (121-130 of 123) with videos related to

Sort By:

Pageof 13

You have reached the last page of results.This site can display upto 123 results.

Science Translational Medicine|October 22, 2020

Toward allele-specific targeting therapy and pharmacodynamic marker for spinocerebellar ataxia type 3Mercedes Prudencio, Hector Garcia-Moreno, Karen R Jansen-West, et al.

Science Translational Medicine|March 31, 2017

Poly(GP) proteins are a useful pharmacodynamic marker for <i>C9ORF72</i>-associated amyotrophic lateral sclerosisTania F Gendron, Jeannie Chew, Jeannette N Stankowski, et al.

Nature Medicine|September 22, 2022

Temporal order of clinical and biomarker changes in familial frontotemporal dementiaAdam M Staffaroni, Melanie Quintana, Barbara Wendelberger, et al.

Pageof 13